We analyzed whether presence of CI assessed by MoCA alters plasma levels of HMGB1, sRAGE, ROS/RNS, ApoD, and NRF2 in the AUD group, compared to those of the AD and control groups (Figure 2). The gene discussed is NFE2L2; the disease is Alzheimer disease.